Shirota T, Hayashi O, Uchida H, Tonozuka N, Sakai N, Itoh H
Department of Internal Medicine, Tokyo Medical College Hospital, Japan.
Ann Hematol. 1993 Jul;67(1):45-7. doi: 10.1007/BF01709666.
The authors report an unusual case of myelodysplastic syndrome (MDS) associated with relapsing polychondritis (RP), which developed at almost the same time as MDS. The initial diagnosis was MDS, refractory anemia (RA) subtype, according to the FAB classification. Symptoms of RP were apparently controlled by oral administration of prednisolone (PSL), although MDS was not. Within 1 month after the diagnosis, monocytosis and thrombocytopenia without excess of blasts became prominent and transformation from RA to chronic myelomonocytic leukemia (CMML) was recognized. Combination chemotherapy including daunorubicin (DNR) and cytosine arabinoside (ara-c) did not subdue the progressive monocytosis and thrombocytopenia. Finally, the patient died of pulmonary hemorrhage 3 months after the onset of the disease. The prognosis of MDS may be poorly influenced by association with RP.
作者报告了一例罕见的骨髓增生异常综合征(MDS)合并复发性多软骨炎(RP)的病例,二者几乎同时发病。根据FAB分类,最初诊断为MDS,难治性贫血(RA)亚型。尽管MDS未得到控制,但RP的症状通过口服泼尼松龙(PSL)明显得到了控制。诊断后1个月内,单核细胞增多症和血小板减少症显著,且无原始细胞增多,随后发现疾病从RA转变为慢性粒单核细胞白血病(CMML)。包括柔红霉素(DNR)和阿糖胞苷(ara-c)在内的联合化疗未能抑制进行性单核细胞增多症和血小板减少症。最终,患者在发病3个月后死于肺出血。MDS合并RP可能对预后产生不良影响。